Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Naval Daver
Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Cancer
Cancer Research
Oncology
Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications
Oncologist
Cancer Research
Medicine
Oncology
Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies
American Journal of Hematology
Hematology
Outcome of Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia After Blinatumomab Failure: No Change in the Level of CD19 Expression
American Journal of Hematology
Hematology
Prognostic Significance of Additional Chromosomal Abnormalities at the Time of Diagnosis in Patients With Chronic Myeloid Leukemia Treated With Frontline Tyrosine Kinase Inhibitors
American Journal of Hematology
Hematology
Treatment of Hairy Cell Leukemia During Pregnancy: Are Purine Analogues and Rituximab Viable Therapeutic Options
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Biological and Clinical Features of Trisomy 21 in Adult Patients With Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
An Exciting New Era in the Treatment of Myeloproliferative Neoplasms
Oncology & Hematology Review (US)
